Reference
Wu X, et al. Successful targeting of the NRG1 fusion reveals durable response to afatinib in lung adenocarcinoma: A case report. Annals of Translational Medicine 9: 1507, No. 19, Oct 2021. Available from: URL: http://doi.org/10.21037/atm-21-3923
Rights and permissions
About this article
Cite this article
Afatinib/catequentinib. Reactions Weekly 1885, 36 (2021). https://doi.org/10.1007/s40278-021-06795-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-021-06795-7